Jasper Therapeutics Inc share price logo

Jasper Therapeutics Inc Share Price

NASDAQ: JSPR

Small Cap

$0.93

+0.01

(+0.75%)

Live

as on

Jasper Therapeutics Inc Stock Performance

as on April 15, 2026 at 4:10 am IST

  • Day's Low

    Day's High

    $0.85
    $0.96
    downward going graph

    8.60%

    Downside

    3.23%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.62
    $7.19
    downward going graph

    33.01%

    Downside

    673.12%

    Upside

    downward going graph

Jasper Therapeutics Inc share price movements today

Previous Close
$0.92
Open
$0.94
Volume
451.8K
Day's Low - High
$0.85 - $0.96
52 Week Low - High
$0.62 - $7.19

Jasper Therapeutics Inc Historical Returns

1 Month Return
-24.67 %
3 Month Return
-43.27 %
1 Year Return
-78.12 %
3 Year Return
-93.66 %
5 Year Return
0 %

Jasper Therapeutics Inc Stock Fundamentals & Key Indicators

Check Jasper Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.5M

EPS (TTM)

-2.44

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-80.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-230.31%

Jasper Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jasper Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Jasper Therapeutics Inc image
Jasper Therapeutics Inc
BUY$22.5MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B140.76%138.848.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.0B102.67%28.532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$35.6BNA124.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B55.14%18.0531.41%

Stock Returns calculator for Jasper Therapeutics Inc Stock including INR - Dollar returns

The Jasper Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Jasper Therapeutics Inc investment value today

Current value as on today

₹23,953

Returns

-₹76,047

(-76.05%)

Returns from Jasper Therapeutics Inc Stock

-₹77,857 (-77.86%)

Dollar Impact

₹1,810 (+1.81%)

Analyst Recommendation on Jasper Therapeutics Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Jasper Therapeutics Inc. Average target price of $7.7

Jasper Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Jasper Therapeutics Inc.

What analysts predicted

87.92%UPSIDE

Target Price

$7.7

Current Price

$0.93

Analyzed by

13 Analysts

Target

$7.70

Jasper Therapeutics Inc target price $7.7, a slight upside of 87.92% compared to current price of $0.93. According to 13 analysts rating.

Jasper Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Jasper Therapeutics Inc Stock has increased by 163% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:163% versus previous 30 day period

Jasper Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
2
-
-
-
1
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
-
0
Operating Income
-19
-17
-15
-15
-19
-25
-21
-27
-19
-12
EBITDA
-19
-17
-14
-15
-19
-25
-21
-26
-18
-15
Interest Expense
-
0
-
-
-
5
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-17
-16
-13
-14
-18
-24
-21
-26
-18
-9
Income Tax Expense
-1
1
0
0
-
0
-
-
-
-
Net Income
-17
-16
-13
-14
-18
-24
-21
-26
-18
-9
Net Profit Margin
0.00%
-808.04%
0.00%
0.00%
0.00%
-2071.64%
0.00%
0.00%
0.00%
0.00%

Jasper Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
6
13
-
-
-
Gross Profit
0
0
-1
-1
-1
-1
Operating Income
-20
-36
-51
-68
-76
-80
EBITDA
-31
-36
-50
-67
-74
-82
Interest Expense
10
6
13
-
-
-
Depreciation
-
0
0
1
1
1
Income Before Tax
-31
-30
-37
-64
-71
-75
Income Tax Expense
0
-1
-13
-1
-1
-
Net Income
-31
-30
-37
-64
-71
-75
Net Profit Margin
0.00%
-494.46%
-278.92%
0.00%
0.00%
0.00%

Jasper Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-16
-13
-14
-18
-24
-21
-26
-18
8
Operating Cash Flow
-16
-15
-11
-14
-21
-22
-15
-16
-21
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
47
0
0
0
-
6
28
0
Change in Cash
-16
31
-11
-14
-20
-22
-9
11
-22

Jasper Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-30
-37
-64
-71
-75
Operating Cash Flow
-18
-33
-45
-52
-62
-77
Investing Cash Flow
0
-2
0
0
0
0
Financing Cash Flow
11
100
0
100
47
34
Change in Cash
-6
64
-46
48
-15
-42

Global Institutional Holdings in Jasper Therapeutics Inc

Funds
Holdings
Velan Capital Investment Management LP
9.53%
Millennium Management LLC
1.3%
Vanguard Group Inc
4.74%
Soleus Capital Management, L.P.
0.71%
Knott David M Jr
0.65%
See all

Jasper Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 15 November

    Sun, 07:41 AM

    -

    Rosen Law Firm reminds Jasper investors of November 18 deadline for securities class action regarding misleading statements.

    Sat, 05:56 PM

    -

    Faruqi & Faruqi investigates claims against Jasper, highlighting misleading statements and upcoming lead plaintiff deadline.

Insights on Jasper Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, JSPR stock has moved up by 37.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 157.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 38.7% return, outperforming this stock by 116.8%

About Jasper Therapeutics Inc

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.
OrganisationJasper Therapeutics Inc
Headquarters2200 Bridge Pkwy, Redwood City, CA, United States, 94065
IndustryBiotechnology
CEOMr. Jeetinder Singh Mahal M.B.A.
E-voting on sharesClick here to vote

Key Management of Jasper Therapeutics Inc

Name

Title

Mr. Matthew Ford

Senior Vice President of Human Resources

Dr. Daniel C. Adelman M.D.

Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor

Dr. Luca Di Noto Ph.D.

Senior Vice President of Technical Operations

Dr. Judith Anne Shizuru M.D., Ph.D.

Co-Founder, Member of Scientific Advisory Board & Director

Alex Gray

Head of Investor Relations

Mr. Herbert C. Cross CPA

CFO & Corporate Secretary

Ms. Patricia Carlos

Senior Vice President of Regulatory Affairs & Quality

Mr. Thomas G. Wiggans

Executive Chairman

Mr. Jeetinder Singh Mahal M.B.A.

President, COO, CEO & Director

FAQs

What is Jasper Therapeutics Inc share price today?

Jasper Therapeutics Inc share price today is $0.93 as on . Jasper Therapeutics Inc share today touched a day high of $0.96 and a low of $0.85.

What is the 52 week high and 52 week low for Jasper Therapeutics Inc share?

Jasper Therapeutics Inc share touched a 52 week high of $7.19 on and a 52 week low of $0.62 on . Jasper Therapeutics Inc stock price today i.e. is trending at $0.93,which is 87.07% down from its 52 week high and 49.28% up from its 52 week low.

What is Jasper Therapeutics Inc's market capitalisation today?

Jasper Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Jasper Therapeutics Inc Stock (JSPR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jasper Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jasper Therapeutics Inc Shares that will get you 1.6129 shares as per Jasper Therapeutics Inc share price of $0.93 per share as on April 14, 2026 at 10:40 pm IST.

What is the minimum amount required to buy Jasper Therapeutics Inc Stock (JSPR) from India?

Indian investors can start investing in Jasper Therapeutics Inc (JSPR) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Jasper Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Jasper Therapeutics Inc share’s latest price of $0.93 as on April 14, 2026 at 10:40 pm IST, you will get 10.7527 shares of Jasper Therapeutics Inc. Learn more about fractional shares .